Healthcare and Medical Devices

Latest Research On Cancer Treatment Market  The global cancer treatment market was valued at around USD 91,591 million in 2017 registering a CAGR of 13.1% during the forecast period, 2019–2026, according to a new Straits Research study. Today, a huge population across the globe is suffering from numerous types of cancer, including blood cancer, lung cancer, colorectal cancer, prostate cancer, breast cancer, cervical cancer, among others — the second leading cause of death. For instance, approximately 8.8 million people died from cancer in 2015, and 9.6 million in 2018, WHO. It has been found that the prevalence of cancer is high among the geriatric population; to be precise, 77% of all cancers are diagnosed in people aged 60 and above. A study suggested that lung, liver, stomach, colorectal, and prostate cancers killed more men than other cancers worldwide in 2018. The Cancer Treatment market report is the most important research for who looks for complete information o...

Latest Survey On Ovarian Cancer Market The global ovarian cancer drugs market was valued at USD 1,246 million in 2017 and is expected to exhibit a phenomenal CAGR of 23.4% during the forecast period 2019-2026, according to a new Straits Research study. Ovarian cancer is caused to the ovaries which are women reproductive system. Ovarian cancers start at the distal end of the fallopian tubes and spread to ovaries and the whole body in cancerous and low malignant potential cases. The lining of ovaries is made up of 3 types of cells and each type of cell can develop into a different type of tumors which can be both benign and malignant. Various diagnostics tests are available for the detection of the ovarian cancers including a blood test, pelvic examination, ultrasound, and several other tests such as PET scan, magnetic resonance imaging (MRI) & CT scan. Two systems are used in the staging of ovarian cancer, International Federation of Gynecology and Obstetrics system (FIGO) and the...

Latest Survey On Cancer Stem Cell Market The global cancer stem cells market size was valued at USD 745.5 million in 2017. The market is expected to expand at a CAGR of 10.58% during the forecast period, according to a new Straits Research study. Increasing application of stem cell therapy in cell transplant and treatment of cancers such as leukemia, lymphoma, multiple myeloma, and neuroblastoma is facilitating the growth of the market. According to the World Health Organization (WHO), in 2015, approximately 8.8 million people died due to cancer. Increasing prevalence of cancer such as blood cancer, lung cancer, colorectal cancer, prostate cancer, breast cancer, and cervical cancer worldwide is influencing the growth of the cancer stem cell market. Growing stem cell-based clinical trials and growing funding stem cell research is propelling the growth of the market. For instance, in 2016to researchers at the Department of Cancer Biology, Mayo Clinic developed a combination therapy u...

Assisted Reproductive Technology PCOS is one of the major factors to cause infertility in women. Changing lifestyle, increasing stress and obesity in women lead to PCOS. Furthermore, increasing consumption of alcohol, smoking and stress have affected sperm mortality in men. Infertility stigma is an important issue, which needs to be addressed. Mostly in developing countries, many experience difficulty discussing infertility with their partner or healthcare provider due to cultural reasons or persistent perceptions that it is a social, rather than medical condition. In addition, availability of a lot of treatment options have made it easier for people to overcome this problem. Global assisted reproductive technology market accounted for over USD 24.5 billion in 2017 and is expected to grow at a CAGR of 11.5% during the forecast period, 2019–2026, according to a new Straits Research study. The Assisted Reproductive Technology market report covers all information on the Gl...

Hepatitis B Therapeutics  Market:  Increasing the prevalence of Hepatitis B across the globe is major driving the growth of the hepatitis B therapeutics market. Rising incidence of hepatitis B in the western Pacific Region and African Region, where 6.2% and 6.1% respectively of the adult population is infected. Furthermore, in the Eastern Mediterranean Region, South-East Asia Region, America and European Region 3.3%, 2.0%, 0.7% and 1.6% of the general population is infected, respectively. According to the WHO, increasing prevalence of Hepatitis B in infants infected from their mothers. Hepatitis B is widely spread from mother to child at birth and especially from an infected child to an uninfected child during the first 5 years of life. Recommended 3-dose schedule of hepatitis B vaccine for the prevention of hepatitis B virus. Straits Research published a report based on the  Hepatitis B Therapeutics industry . The key objective of this report is to highlight...

Heart Pump Device Market Outlooks (2019-2026) Straits Research has announced the addition of a new report titled, “ Heart Pump Device Market ”, into its vast repository of research reports. This research report evaluates the industry status, market size, competitive landscape, market share, and growth opportunity. Then, the report provides an in-depth study of all the leading factors influencing the market on a global and regional level, including key drivers, challenges, opportunities, restraints, threats, and industry-specific trends. The global heart pump device market was valued around USD 1,620 Million in 2017 and expected to register CAGR of 21.4% in the forecast period. The research report takes into consideration the drivers, restraints, trends, and opportunities of the Heart Pump Device market in order to identify the future of the market. The report also provides an estimation of the overall market size in terms of both value and volume and offers qualitative ...